Cannabis and Hemp Industry Investment News
On April 22, 2026, Acting Attorney General Todd Blanche signed an order placing state-licensed medical marijuana into Schedule III of the Controlled S...
For much of the cannabinoid supply market, the model has been simple: make the molecule, test the batch, sell the material. If the product meets basic...
Over the last several years, we have spent a lot of time studying how cannabis retailers make purchasing decisions. Not just which products they buy, ...
For years, cannabis operators have accepted labeling inefficiencies as an unavoidable cost of doing business. Yet, many facilities still rely on fragm...
Every conversation about cannabis risk follows the same script: Regulatory uncertainty, 280E, capital access, and maybe interstate commerce, depending...
The Hemp Beverage Expo (HBE) heads into its second show this June in Austin, Texas, and the energy is full speed ahead — even with November 12th loomi...
LeafLink’s Wholesale Cannabis Pricing Guide, drawing on over 400,000 SKUs and billions of dollars in transaction data across 18 U.S. markets throughou...
The April 2026 Department of Justice rescheduling order landed with the weight of a decade of advocacy behind it. For an industry that has watched eve...
Pre-rolls generated $4 billion in sales in 2025 and are projected to grow faster than any other top cannabis category, at a 10% compound annual growth...
SOCi’s 2026 Local Visibility Index analyzed more than 350,000 business locations across 2,751 brands and found a gap every dispensary operator should ...
Choosing between glass and plastic packaging for cannabis concentrates is a strategic decision with downstream consequences for product integrity, com...
Cannabis cultivation is, at its core, a controlled environment business, and air quality remains one of the most consistently underestimated variables...
Most cannabis operators have a banking problem. For many, that means limited access to financial services, forcing the business to operate largely in ...
Legalization has been framed as a turning point for cannabis safety, transparency, and adoption for years, but now, over a decade since recreational c...
As U.S. cannabis rescheduling moves forward and export opportunities to the European Union become available, a new certification tool to help producer...
The U.S. cannabis industry generated more than $30 billion in regulated sales in 2025, yet profitability has become harder to predict. According to a ...
As cannabis becomes a globally traded medical commodity, cGMP compliance is reshaping how it is grown, handled, and transported. For operators working...
Picture the moment a cannabis company’s compliance team gets copied on an email from a banking partner’s risk officer. The subject line says “Question...
Cannabis packaging decisions have downstream consequences for compliance, operations, customer perception, and margins. This article offers a practica...
Driven by innovation and convenience, pre-roll sales in 2025 not only had the strongest growth of any major category, topping $3.6 billion in sales an...
